TriSalus Life Sciences (TLSIW) Inventory (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Inventory data on file, last reported at $3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 9.23% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 9.23% YoY), and the FY2025 full-year result was $3.1 million, down 23.99% from the prior year.
• Inventory for Q1 2026 stood at $3.8 million, up from $3.1 million in the prior quarter.
• Across five years, Inventory topped out at $4.2 million in Q1 2025 and bottomed at $1.5 million in Q4 2022.
• The 5-year median for Inventory is $3.4 million (2024), against an average of $3.2 million.
• The widest annual swing landed in 2024, when Inventory surged 145.49%; it then declined 23.99% in 2025.
• A 5-year view of Inventory shows it stood at $1.5 million in 2022, then soared by 73.01% to $2.5 million in 2023, then surged by 59.06% to $4.0 million in 2024, then fell by 23.99% to $3.1 million in 2025, then advanced by 22.78% to $3.8 million in 2026.
• The last three Inventory figures came in at $3.8 million (Q1 2026), $3.1 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison